Stock A950210 PRESTIGE BIOPHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Prestige BioPharma Limited

Equities

A950210

KR8702070002

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 02/07/2024 BST 		5-day change 1st Jan Change
8,900 KRW +1.60% Intraday chart for Prestige BioPharma Limited +0.68% -6.12%
2023 Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer CI
2023 Prestige BioPharma Limited Develops First-In-Class PAUF-detecting Diagnostic Kit CI

Chart calendar Prestige BioPharma Limited

852772c6c8566310fd701830.F9IvNj6Gv2YzcO-8EBDmOqEwb2AMbi1OugnrB2JTyOQ.dJBnWQzD_hMEOLjLRSSza9JUCDZiGGkpyWGKNiE_irtbmB5UdMXxUAEEnA~2d689e648fe67180c701d52b8d64bbb6

Upcoming events on Prestige BioPharma Limited

16/09/2024 Q4 2024 Earnings Release (Projected)
25/11/2024 Q1 2025 Earnings Release (Projected)
26/02/2025 Q2 2025 Earnings Release (Projected)
27/05/2025 Q3 2025 Earnings Release (Projected)

Past events on Prestige BioPharma Limited

29/05/2024 Q3 2024 Earnings Release
26/09/2023 02:30 Annual General Meeting
17/09/2023 Q4 2023 Earnings Release
07/05/2023 07:50 Investor Meeting
01/03/2023 Q2 2023 Earnings Release
28/11/2022 Q1 2023 Earnings Release
20/09/2022 FY 2022 Earnings Release
29/05/2022 Q3 2022 Earnings Release
06/03/2022 European Society for Medical Oncology Targeted Anticancer Therapies Congress
27/05/2021 Q3 2021 Earnings Release

Annual results

Fiscal PeriodJune 2020 2021
Net sales
Billions KRW		Released
Forecast
Spread 		0,00


0,00
1,00
-
EBITDA
Billions KRW		Released
Forecast
Spread 		0,00


-19,1
-19,0
-0.62%
EBIT
Billions KRW		Released
Forecast
Spread 		0,00


-18,8
-19,0
1.13%
Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		-14,9


-7,66
-19,0
59.69%
Net income
Billions KRW		Released
Forecast
Spread 		-15,0


-7,69
-19,0
59.51%
EPS
KRW		Released
Forecast
Spread 		0,00


-744
-361
-106.15%
Announcement Date22/01/2112/08/21

Upcoming sector events for Prestige BioPharma Limited

11/07/2024 07:00 BONESUPPORT HOLDING AB: Q2 2024 Earnings Release
15/07/2024 SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release
23/07/2024 07:00 BIOGAIA AB: Q2 2024 Earnings Release
23/07/2024 SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected)
24/07/2024 PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected)
24/07/2024 GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected)
25/07/2024 06:00 UCB: Q2 2024 Earnings Release
25/07/2024 SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected)
29/07/2024 BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 INCYTE CORPORATION: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Prestige BioPharma Limited

23/05/2024 10:43 CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release
14/05/2024 16:35 GRIFOLS, S.A.: Q1 2024 Earnings Release
13/05/2024 NATURECELL CO.,LTD.: Q1 2024 Earnings Release
09/05/2024 PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release
09/05/2024 MEDY-TOX INC.: Q1 2024 Earnings Release
09/05/2024 21:05 AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release
09/05/2024 21:05 ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release
09/05/2024 07:30 NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release
08/05/2024 HUGEL, INC.: Q1 2024 Earnings Release
08/05/2024 21:16 CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A950210 Stock
  4. Calendar Prestige BioPharma Limited